StockDriftsStockDriftsTop 24 Decheng Capital Management Iii (Cayman), Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ALPN | Alpine Immune Sciences, Inc. | 25.63% | 6.71M | $76.8M | +0.00%(+0) | — | 2023-09-30 | |
| ZNTL | Zentalis Pharmaceuticals Inc. | 14.06% | 2.10M | $42.1M | +0.00%(+0) | — | 2023-09-30 | |
| AURA | Aura Biosciences, Inc. | 6.09% | 1.16M | $18.2M | +296.52%(+869.79K) | — | 2023-09-30 | |
| ROIV | ROIVANT SCIENCES LTD | 5.69% | 1.46M | $17.0M | new | — | 2023-09-30 | |
| SLRN | ACELYRIN INC(NSM) | 5.26% | 1.55M | $15.7M | -0.39%(-6.10K) | — | 2023-09-30 | |
| RCUS | Arcus Biosciences, Inc | 5.21% | 869.8K | $15.6M | new | — | 2023-09-30 | |
| PACB | Pacific Biosciences of California, Inc. | 4.08% | 1.46M | $12.2M | +0.00%(+0) | — | 2023-09-30 | |
| ILMN | Illumnia, Inc. | 3.7% | 80.9K | $11.1M | +0.00%(+0) | — | 2023-09-30 | |
| LNTH | LANTHEUS HOLDINGS INC(NMS) | 3.3% | 142.2K | $9.9M | new | — | 2023-09-30 | |
| HZNP | Horizon Therapeutics PLC | 3.05% | 78.9K | $9.1M | +0.00%(+0) | — | 2023-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Decheng Capital Management Iii (Cayman), Llc reports $299.64M in US-listed equity holdings across 26 positions in its most recent 13F filing. Its largest disclosed positions are ALPN (25.6%), ZNTL (14.1%) and AURA (6.1%). Figures reflect the Q3 2023 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Decheng Capital Management Iii (Cayman), Llc, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Decheng Capital Management Iii (Cayman), Llc’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1747821). View Decheng Capital Management Iii (Cayman), Llc’s 13F filings on SEC